Search Results

BUD Anheuser-Busch InBev SA/NV - Fundamental Analysis

NEUTRAL
Sign in to save Save this symbol to a watchlist or track a position.
BUD Stock | Fundamental Analysis & Investment Insights
NYSE Consumer Defensive Beverages - Brewers
Current Price Live
$69.88
Analyst Target
$78.1
+11.8% Upside
52W High
$72.13
52W Low
$47.89

At a glance

Key valuation, profitability, growth, and risk metrics.

Unlock key metrics

Market cap, P/E, ROE, margins, leverage and more.

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
65%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant operational and profitability concerns. Despite this, the stock trades above its Graham Number of $52.90 at $69.88, supported by a bullish analyst recommendation and strong recent price performance. Earnings growth has collapsed year-over-year (-48.6%), yet the company consistently beats estimates, showing some earnings quality. Profit margins and cash flow generation remain solid, but missing key financial health metrics like ROE, ROA, and Altman Z-Score limits confidence in stability. The dividend is sustainable with a 37.5% payout ratio, but insider sentiment and technical trend are weak.

Key Strengths

Consistent earnings beat streak with 3 out of last 4 quarters exceeding estimates and a 5.93% average surprise
High gross margin of 55.90% reflects strong pricing power and cost control in brewing operations
Solid operating margin at 27.79%, outperforming sector average profit margin of -1.59%
Debt/Equity of 0.83 is below sector average of 1.73, indicating relatively conservative leverage
Analyst target price of $78.10 implies 11.8% upside, with unanimous buy recommendation from 10 analysts

Key Risks

Critically low Piotroski F-Score of 2/9 signals deteriorating financial health and weak earnings quality
Earnings growth has collapsed YoY (-48.6%) and QoQ (-49.1%), raising sustainability concerns
Missing key financial health data (ROE, ROA, Altman Z-Score, cash/debt figures) creates opacity and risk
Technical trend score of 10/100 indicates strong bearish momentum despite long-term price gains
Forward P/E of 16.74 is optimistic given near-zero revenue growth (0.6% YoY) and declining earnings
AI Fair Value Estimate
Based on comprehensive analysis
$58.0
-17.0% below current price

Performance Snowflake

Multi-dimensional AI analysis across 5 key categories

Unlock AI-Powered Analysis

See Value, Future Performance, Past Performance, Financial Health & Dividend scores

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Unlock Price Charts

View historical price trends and analyst targets

Historical Performance Trends

Long-term financial metrics and growth patterns

Unlock Historical Data

View 3-year revenue, profit margins, and growth trends

Valuation Metrics

Key valuation ratios and pricing indicators

Sign up to view

P/E, P/B, P/S, EV/EBITDA and more

Profitability, Growth & Financial Health

Detailed profit margins, ROE, debt ratios, and liquidity metrics

Unlock Detailed Metrics

View ROE, Operating Margin, Debt/Equity, Current Ratio and more

Sector Comparison & Peer Analysis

Compare BUD against industry averages and similar companies

Unlock Sector Insights

See how BUD compares to competitors and industry standards

Insider Trading & Analyst Ratings

Track insider transactions and Wall Street analyst recommendations

Unlock Insider Data

See recent insider buys/sells and analyst price targets

Past News Coverage

Recent headlines mentioning BUD from our newsroom.

Newest → oldest

See the full BUD analysis

Free signup • Unlock all metrics • No credit card required

TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile